Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct;41(10):2809-2814.
doi: 10.12669/pjms.41.10.12535.

Ultra-Widefield Fluorescein Angiography-Based Targeted Retinal Photocoagulation versus Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: A Randomized Controlled Trial

Affiliations

Ultra-Widefield Fluorescein Angiography-Based Targeted Retinal Photocoagulation versus Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: A Randomized Controlled Trial

Imran Ahmad et al. Pak J Med Sci. 2025 Oct.

Abstract

Objective: To compare the safety and efficacy of ultra-widefield fluorescein angiography-based targeted retinal photocoagulation with panretinal photocoagulation for the treatment of proliferative diabetic retinopathy.

Methodology: This randomized controlled trial was conducted from September 1, 2022, to February 28, 2024. Patients with proliferative diabetic retinopathy were randomly allocated to targeted retinal photocoagulation (TRP) and panretinal photocoagulation (PRP). In TRP group, the laser was applied only to the ischemic area demarcated by ultra-widefield fluorescein angiography, whereas in PRP group, the conventional PRP laser photocoagulation protocol was followed. Data was gathered for the treatment effects on best corrected visual acuity (BCVA), central macular thickness (CMT), mean deviation (MD) and visual field index (VFI).

Results: A total of 120 participants were recruited during the study period, with 60 in each group. The mean age was 65.66 ± 9.33 years with 64 (53.3%) males. There was no statistically significant difference between the two groups at baseline and after the treatment for BCVA, CMT, MD and VFI. When compared within the groups, CMT improved from baseline which was statistically significant (p=0.002) in TRP group. The PRP group also showed significant improvement in CMT from baseline (p=0.01), but MD and VFI worsened significantly from the baseline (p<0.001).

Conclusions: Targeted retinal and panretinal photocoagulation are equally effective in reversing proliferative diabetic retinopathy, but panretinal photocoagulation negatively affects mean deviation and visual field index.

Keywords: Diabetic retinopathy; Fluorescein angiography; Laser photocoagulation; Panretinal photocoagulation; Targeted retinal photocoagulation.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None.

Figures

Fig.1
Fig.1
CONSORT 2010 Flow Diagram.

References

    1. Mudassir HA, Arshad SMT, Naheed M, Anwer S. Effect of Centratherum anthelminticum seeds on Glycated hemoglobin, cardiovascular disease risks and dyslipidemia in Type-2 diabetic patients in Karachi:A non-blind randomized controlled trial. Pak J Med Sci. 2025;41(1):257–262. doi:10.12669/pjms.41.1.8496. - PMC - PubMed
    1. Azeem S, Khan U, Liaquat A. The increasing rate of diabetes in Pakistan:A silent killer. Ann Med Surg. 2022;79 doi:10.1016/j.amsu.2022.103901. - PMC - PubMed
    1. Sabanayagam C, Yip W, Ting DS, Tan G, Wong TY. Ten Emerging Trends in the Epidemiology of Diabetic Retinopathy. Ophthalmic Epidemiol. 2016;23(4):209–222. doi:10.1080/09286586.2016.1193618. - PubMed
    1. Mohamed Z, Vankudre GS, Ayyappan JP, Noushad B, Alzeedi AN, Alazzani SS, et al. Vision-Related Quality of Life Among Diabetic Retinopathy Patients in a Hospital-Based Population in the Sultanate of Oman. Clin Optom. 2024;16:123–129. doi:10.2147/OPTO.S462498. - PMC - PubMed
    1. Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol. 1976;81(4):383–396. doi:10.1016/0002-9394(76)90292-0. - PubMed

LinkOut - more resources